Allosteric modulation of binding properties between units of chemokine receptor homo- and hetero-oligomers

Molecular Pharmacology

Volumn 69, Issue 5, 2006, Pages 1652-1661

  Springael, Jean Yves ^a   Minh, Phu Nguyen Le ^a   Urizar, Eneko ^a   Costagliola, Sabine ^a   Vassart, Gilbert ^a   Parmentier, Marc ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR AGONIST; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATE DERIVATIVE; HETERODIMER; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 2D7; MONOCLONAL ANTIBODY CTC5; MONOCLONAL ANTIBODY DOC 1; MONOCLONAL ANTIBODY DOC 2; MONOCLONAL ANTIBODY MAB150; MONOCLONAL ANTIBODY MC 1; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOMER; N [4 [[[6,7 DIHYDRO 2 (4 METHYLPHENYL) 5H BENZOCYCLOHEPTEN 8 YL]CARBONYL]AMINO]BENZYL] N,N DIMETHYL 2H TETRAHYDROPYRAN 4 AMINIUM CHLORIDE; OLIGOMER; PERTUSSIS TOXIN; RADIOLIGAND; RANTES; RECEPTOR ANTIBODY; TRACER; UNCLASSIFIED DRUG;

AGONIST; ALLOSTERISM; ANIMAL CELL; ARTICLE; BINDING ASSAY; BINDING KINETICS; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CELL STRAIN HEK293; CHO CELL; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CYTOKINE RELEASE; DILUTION; DIMERIZATION; DISSOCIATION; DRUG RECEPTOR BINDING; EMBRYO; HUMAN; HUMAN CELL; ISOTOPE LABELING; KINETICS; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR UPREGULATION; STIMULATION;

EID: 33645802812     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.105.019414     Document Type: Article

References (50)

1. Baneres JL and Parello J (2003) Structure-based analysis of GPCR function: evidence for a novel pentameric assembly between the dimeric leukotriene B-4 receptor BLT1 and the G-protein. J Mol Biol 329:815-829.
2. Benkirane M, Jin DY, Chun RF, Koup RA, and Jeang KT (1997) Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by Ccr5 32. J Biol Chem 272:30603-30606.
3. Berger EA, Murphy PM, and Farber JM (1999) Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism and disease. Annu Rev Immunol 17:657-700.
4. Blanpain C, Doranz BJ, Vakili J, Rucker J, Govaerts C, Baik SS, Lorthioir O, Migeotte I, Libert F, Baleux F, et al. (1999) Multiple charged and aromatic residues in CCR5 amino-terminal domain are involved in high affinity binding of both chemokines and HIV-1 Env protein. J Biol Chem 274:34719-34727.
5. Blanpain C, Vanderwinden JM, Cihak J, Wittamer V, Le Poul E, Issafras H, Stangassinger M, Vassart G, Marullo S, Schlondorff D, et al. (2002) Multiple active states and oligomerization of CCR5 revealed by functional properties of monoclonal antibodies. Mol Cell Biol 13:723-737.
6. Bulenger S, Marullo S, and Bouvier M (2005) Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation. Trends Pharmacol Sci 26:131-137.
7. Carayon P, Guibout M, and Lissitzky S (1979) The interaction of radioiodinated thyrotropin with human plasma membranes from normal and diseased thyroid glands. Relation of thyrotropin binding to adenylate cyclase activity. Ann Endocrinol (Paris) 40:211-227.
8. Christopoulos A and Kenakin T (2002) G protein-coupled receptor allosterism and complexing. Pharmacol Rev 54:323-374.
9. Christopoulos A, Lanzafame A, Ziegler A, and Mitchelson F (1997) Kinetic studies of co-operativity at atrial muscarinic M2 receptors with an "infinite dilution" procedure. Biochem Pharmacol 53:795-800.
10. Clore GM, Appella E, Yamada M, Matsushima K, and Gronenborn AM (1990) Three-dimensional structure of interleukin 8 in solution. Biochemistry 29:1689-1696.
11. De Lean A, Stadel JM, and Lefkowitz RJ (1980) A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled β-adrenergic receptor. J Biol Chem 255:7108-7117.
12. de Meyts P (1976) Cooperative properties of hormone receptors in cell membranes. J Supramol Struct 4:241-258.
13. de Meyts P, Roth J, Neville DM Jr, Gavin JR, and Lesniak MA (1973) Insulin interactions with its receptors: experimental evidence for negative cooperativity. Biochem Biophys Res Commun 55:154-161.
14. El Asmar L, Springael JY, Ballet S, Andrieu EU, Vassart G, and Parmentier M (2005) Evidence for negative binding cooperativity within CCR5-CCR2b heterodimers. Mol Pharmacol 67:460-469.
15. Farrens DL, Altenbach C, Yang K, Hubbell WL, and Khorana HG (1996) Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin. Science (Wash DC) 274:768-770.
16. Filipek S, Krzysko KA, Fotiadis D, Liang Y, Saperstein DA, Engel A, and Palczewski K (2004) A concept for G protein activation by G protein-coupled receptor dimers: the transducin/rhodopsin interface. Photochem Photobiol Sci 3:628-638.
17. Fotiadis D, Liang Y, Filipek S, Saperstein DA, Engel A, and Palczewski K (2003) Atomic-force microscopy: rhodopsin dimers in native disc membranes. Nature (Lond) 421:127-128.
18. Frade JMR, Llorente M, Mellado M, Alcami J, GutierrezRamos JC, Zaballos A, delReal G, and MartinezA C (1997) The amino-terminal domain of the CCR2 chemokine receptor acts as coreceptor for HIV-1 infection. J Clin Investig 100: 497-502.
19. Gales C, Rebois RV, Hogue M, Trieu P, Breit A, Hebert TE, and Bouvier M (2005) Real-time monitoring of receptor and G-protein interactions in living cells. Nat Methods 2:177-184.
20. Gerard C and Rollins BJ (2001) Chemokines and disease. Nat Immunol 2:108-115.
21. Gether U (2000) Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr Rev 21:90-113.
22. Gong JH and Clark-Lewis I (1995) Antagonists of monocyte chemoattractant protein 1 identified by modification of functionally critical NH2-terminal residues. J Exp Med 181:631-640.
23. Gong JH, Uguccioni M, Dewald B, Baggiolini M, and Clark-Lewis I (1996) RANTES and MCP-3 antagonists bind multiple chemokine receptors. J Biol Chem 271: 10521-10527.
24. Goudet C, Kniazeff J, Hlavackova V, Malhaire F, Maurel D, Acher F, Blahos J, Prezeau L, and Pin JP (2005) Asymmetric functioning of dimeric metabotropic glutamate receptors disclosed by positive allosteric modulators. J Biol Chem 280:24380-24385.
25. Gouldson PR, Snell CR, Bywater RP, Higgs C, and Reynolds CA (1998) Domain swapping in G-protein coupled receptor dimers. Protein Eng 11:1181-1193.
26. Guo W, Shi L, and Javitch JA (2003) The fourth transmembrane segment forms the interface of the dopamine D2 receptor homodimer. J Biol Chem 278:4385-4388.
27. Hernanz-Falcon P, Rodriguez-Frade JM, Serrano A, Juan D, del Sol A, Soriano SF, Roncal F, Gomez L, Valencia A, Martinez A, et al. (2004) Identification of amino acid residues crucial for chemokine receptor dimerization. Nat Immunol 5:216-223.
28. Hlavackova V, Goudet C, Kniazeff J, Zikova A, Maurel D, Vol C, Trojanova J, Prezeau L, Pin JP, and Blahos J (2005) Evidence for a single heptahelical domain being turned on upon activation of a dimeric GPCR. EMBO (Eur Mol Biol Organ) J 24:499-509.
29. Issafras H, Angers S, Bulenger S, Blanpain C, Parmentier M, Labbe-Jullie C, Bouvier M, and Marullo S (2002) Constitutive agonist-independent CCR5 oligomerization and antibody-mediated clustering occurring at physiological levels of receptors. J Biol Chem 277:34666-34673.
30. Kenakin T (1996) Receptor conformational induction versus selection: all part of the same energy landscape. Trends Pharmacol Sci 17:190-191.
31. Kniazeff J, Bessis AS, Maurel D, Ansanay H, Prezeau L, and Pin JP (2004) Closed state of both binding domains of homodimeric MGlu receptors is required for full activity. Nat Struct Mol Biol 11:706-713.
32. Koshland J (1996) The structural basis of negative cooperativity: receptors and enzymes. Curr Opin Struct Biol 6:757-761.
33. Kostenis E and Mohr K (1996) Two-point kinetic experiments to quantify allosteric effects on radioligand dissociation. Trends Pharmacol Sci 17:280-283.
34. Lagane B, Ballet S, Planchenault T, Balabanian K, Le Poul E, Blanpain C, Percherancier Y, Staropoli I, Vassart G, Oppermann M, et al. (2005) Mutation of the DRY motif reveals different structural requirements for CCR5-mediated signaling and receptor endocytosis. Mol Pharmacol 67:1966-1976.
35. Laurence JS, Blanpain C, De Leener A, Parmentier M, and LiWang PJ (2001) Importance of basic residues and quaternary structure in the function of MIP-1 beta: CCR5 binding and cell surface sugar interactions. Biochemistry 40:4990-4999.
36. Lee B, Sharron M, Blanpain C, Doranz BJ, Vakili J, Setoh P, Berg E, Liu G, Guy HR, Durell SR, et al. (1999) Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function. J Biol Chem 274:9617-9626.
37. Levitzki A (1974) Negative co-operativity in clustered receptors as a possible basis for membrane action. J Theor Biol 44:367-372.
38. Limbird L, de Meyts P, and Lefkowitz RJ (1975) Beta-adrenergic receptors: evidence for negative cooperativity. Biochem Biophys Res Commun 64:1160-1168.
39. Mellado M, Rodriguez-Frade JM, Vila-Coro AJ, Fernandez S, Martin de Ana A, Jones DR, Toran JL, and Martinez A (2001) Chemokine receptor homo- or heterodimerization activates distinct signaling pathways. EMBO (Eur Mol Biol Organ) J 20:2497-2507.
40. 2-adrenergic receptor homo- and heterodimerization by bioluminescence resonance energy transfer. J Biol Chem 277:44925-44931.
41. Murphy PM, Baggiolini M, Charo IF, Hebert CA, Horuk R, Matsushima K, Miller LH, Oppenheim JJ, and Power CA (2000) International Union of Pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 52:145-176.
42. Paavola CD, Hemmerich S, Grunberger D, Polsky I, Bloom A, Freedman R, Mulkins M, Bhakta S, McCarley D, Wiesent L, et al. (1998) Monomeric monocyte chemoattractant protein-1 (MCP-1) binds and activates the MCP-1 receptor CCR2B. J Biol Chem 273:33157-33165.
43. Park PSH, Filipek S, Wells JW, and Palczewski K (2004) Oligomerization of G protein-coupled receptors: past, present and future. Biochemistry 43:15643-15656.
44. Percherancier Y, Berchiche YA, Slight I, Volkmer-Engert R, Tamamura H, Fujii N, Bouvier M, and Heveker N (2005) Bioluminescence resonance energy transfer reveals ligand-induced conformational changes in CXCR4 homo- and heterodimers. J Biol Chem 280:9895-9903.
45. Pizard A, Marchetti J, Allegrini J, Alhenc-Gelas F, and Rajerison RM (1998) Negative cooperativity in the human bradykinin B-2 receptor. J Biol Chem 273:1309-1315.
46. Rabin RL, Park MK, Liao F, Swofford R, Stephany D, and Farber JM (1999) Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signaling. J Immunol 162:3840-3850.
47. Samson M, LaRosa G, Libert F, Paindavoine P, Detheux M, Vassart G, and Parmentier M (1997) The second extracellular loop of CCR5 is the major determinant of ligand specificity. J Biol Chem 272:24934-24941.
48. Springael JY, Urizar E, and Parmentier M (2005) Dimerization of chemokine receptors and its functional consequences. Cytokine Growth Factor Rev 16:611-623.
49. Staudinger R, Wang X, and Bandres JC (2001) Allosteric regulation of CCR5 by guanine nucleotides and HIV-1 envelope. Biochem Biophys Res Commun 286: 41-47.
50. Urizar E, Montanelli L, Loy T, Bonomi M, Swillens S, Gales C, Bouvier M, Smits G, Vassart G, and Costagliola S (2005) Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity. EMBO (Eur Mol Biol Organ) J 24:1954-1964.